Furthermore, we hypothesize that the crosstalk between NF-κB and NRF2 coordinately regulates NBCn1, thereby integrating antioxidant signaling pathways and suggesting that NBCn1 inhibition might represent a novel strategy to treat lung cancer cells. The gene discussed is NFKB1; the disease is lung cancer.